Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Beyondspring Inc

BYSI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.62

▼ -0.66%

Market Cap $25.42M · Vol 4.14K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$25.42M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

29.34

Momentum

Beta

-0.17

vs Market

52W High

$2.40

74.25% below

52W Low

$0.57

9.13% above

Volume

4.14K

Avg 74.84K

P/B

N/A

Price-to-book

ROE

-321.46%

Return on equity

Free Float

82.60%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Beyondspring Inc (BYSI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BYSI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-7.11%

-37.57%

-63.85%

-59.86%

YTD

-62.08%

-66.41%

-33.54%

-97.70%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-8,715,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	-321.46%
ROA · ROIC	-28.63% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	41.12M

Technical Indicators

50-Day SMA	$1.08
200-Day SMA	$1.51
RSI (14)	29.34
Beta	-0.17
52-Week High	$2.40
52-Week Low	$0.57

Volume Today	4.14K
Avg Daily Volume (30D)	74.84K
Relative Volume	0.06x
Volatility (10D)	57.83
Volatility (30D)	131.19
Free Float	82.60%

Analyst Consensus

N/A

Current Price $0.62

Mean Target N/A

52W Low$0.57 52W High$2.40

Current

Target

$0.57 $2.40

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00F9YLSV3

ISINKYG108301006

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -2.54% RVMD Revolution Medicines Inc -0.40% ONC BeOne Medicines AG -1.22% 068270.KS Celltrion Inc +0.53% ABVX Abivax SA +0.66%

Company Profile

BeyondSpring Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to improve clinical outcomes for patients with high unmet medical needs. Its lead asset, Plinabulin, is in late-stage clinical development as an anti-cancer agent in non-small cell lung cancer (NSCLC) and a range of cancer indications. The Company’s mechanism of action as a dendritic cell maturation agent supports both anti-cancer activity and immune modulation, offering an approach to resensitizing tumors to checkpoint inhibitors. It also has a pipeline of immuno-oncology product candidates, BPI-002 program, which is based on an oral small molecule agent that increases T-cell co-stimulation; BPI-003 program, which is based on a small molecule inhibitor of IKK, a protein kinase, and BPI-004 program, which is focused on a small molecule that induces the production of neo-antigens by tumor cells, allowing tumors containing no immune cells to be infiltrated by the immune system.